Intercept Pharmaceuticals, Inc. (ICPT)

Nov 8, 2023 - ICPT was delisted (reason: acquired by Alfasigma)

19.00

0.00 (0.00%)

Inactive · Last trade price on Nov 7, 2023

Intercept Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Nov '23 Nov 7, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Market Capitalization	-	512	481	815	4,056	2,989
Market Cap Growth	-	6.44%	-40.94%	-79.91%	35.71%	103.81%
Enterprise Value	-	361	601	889	3,882	2,867
PE Ratio	-	2.31	-	-	-	-
PS Ratio	-	1.79	1.85	3.48	16.10	16.62
PB Ratio	-	5.50	-2.62	-4.88	78.68	156.24
P/TBV Ratio	-	5.50	-	-	78.68	156.24
EV/Sales Ratio	-	1.26	2.31	3.80	15.40	15.95
Debt / Equity Ratio	3.12	3.57	-2.93	-3.45	10.62	19.41
Asset Turnover	0.67	0.53	0.47	0.35	0.40	0.36
Quick Ratio	3.92	2.24	2.67	2.87	4.26	4.04
Current Ratio	4.22	2.35	3.02	3.05	4.45	4.22
Return on Equity (ROE)	-64.02%	-	-	-	-975.25%	-1741.42%
Return on Assets (ROA)	-7.23%	-7.89%	-11.36%	-20.40%	-30.89%	-35.92%
Return on Invested Capital (ROIC)	-9.27%	-10.91%	-16.46%	-27.02%	-39.46%	-46.80%
Earnings Yield	-	43.30%	-19.00%	-33.73%	-8.50%	-10.35%
FCF Yield	-	-5.34%	-8.61%	-21.57%	-5.86%	-8.06%
Buyback Yield / Dilution	-35.22%	-6.09%	3.26%	-4.16%	-11.21%	-13.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q